- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2009
- Public Summary Document (PSD) March 2009 PBAC Meeting - PDF
Oxybutynin – March 2009
Oxybutynin, transdermal patches, 36 mg (releasing approximately 3.9 mg per 24 hours), 8, Oxytrol® , March 2009
Last updated
3 July 2009
